Freenome, Inc. (FRNM)
15.66
-0.04
(-0.25%)
USD |
NASDAQ |
Sep 24, 09:52
Freenome Enterprise Value : 161.48M for Sept. 23, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 23, 2026 | 161.48M |
| September 22, 2026 | 169.27M |
| September 21, 2026 | 170.77M |
| September 18, 2026 | 176.03M |
| September 17, 2026 | 167.57M |
| September 16, 2026 | 151.48M |
| September 15, 2026 | 150.55M |
| September 14, 2026 | 153.85M |
| September 11, 2026 | 147.77M |
| September 10, 2026 | 152.10M |
| September 09, 2026 | 162.00M |
| September 08, 2026 | 164.48M |
| September 04, 2026 | 167.78M |
| September 03, 2026 | 173.86M |
| September 02, 2026 | 164.06M |
| September 01, 2026 | 156.84M |
| August 31, 2026 | 152.10M |
| August 28, 2026 | 152.10M |
| August 27, 2026 | 143.33M |
| August 26, 2026 | 144.88M |
| August 25, 2026 | 143.85M |
| August 24, 2026 | 141.68M |
| August 21, 2026 | 141.99M |
| August 20, 2026 | 138.90M |
| August 19, 2026 | 140.14M |
| Date | Value |
|---|---|
| August 18, 2026 | 138.28M |
| August 17, 2026 | 133.64M |
| August 14, 2026 | 118.79M |
| August 13, 2026 | 119.30M |
| August 12, 2026 | 118.68M |
| August 11, 2026 | 123.32M |
| August 10, 2026 | 119.41M |
| August 07, 2026 | 114.56M |
| August 06, 2026 | 112.08M |
| August 05, 2026 | 112.08M |
| August 04, 2026 | 112.08M |
| August 03, 2026 | 113.11M |
| July 31, 2026 | 114.56M |
| July 30, 2026 | 102.59M |
| July 29, 2026 | 103.32M |
| July 28, 2026 | 110.64M |
| July 27, 2026 | 116.93M |
| July 24, 2026 | 115.49M |
| July 23, 2026 | 125.39M |
| July 22, 2026 | 135.08M |
| July 21, 2026 | 133.74M |
| July 20, 2026 | 122.81M |
| July 17, 2026 | 122.29M |
| July 16, 2026 | 123.32M |
| July 15, 2026 | 121.98M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Natera, Inc. | 55.27B |
| Intellia Therapeutics, Inc. | 1.362B |
| Twist Bioscience Corp. | 9.861B |
| Ionis Pharmaceuticals, Inc. | 7.411B |
| Veracyte, Inc. | 3.076B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.1149M |
| Total Expenses (Quarterly) | 0.1149M |
| EPS Diluted (Quarterly) | -0.0111 |
| Earnings Yield | -0.44% |
| Normalized Earnings Yield | -0.4406 |